Literature DB >> 570395

beta-Aspartylglycine, a substance unique to caecal contents of germ-free and antibiotic-treated mice.

G W Welling, G Groen.   

Abstract

The caecal supernatants from germ-free, antibiotic-treated and control mice were compared with respect to their content of low-molecular-weight substances (less than 3500 mol. wt.). The supernatants contained about the same amount of free amino acids. After acid hydrolysis, the caecal supernatants of germ-free and antibiotic-treated mice showed a 2.9-fold increase in free amino acids, whereas a similar treatment of the supernatant from control mice resulted in a 2.6-fold increase. By gel filtration on Sephadex G-25, and high-voltage paper electrophoresis at pH 3.5 of the fractions eluted after the void volume, it was found that the caecal supernatants of germ-free and antibiotic-treated mice contained a substance more acidic than aspartic acid. Preparative high-voltage electrophoresis, dansylation, amino acid analysis and a specific colour reaction showed the substance to be beta-aspartylglycine. After a minimal 36 h of treatment with neomycin and bacitracin, a high concentration of beta-aspartylglycine was found, and no enterococci and aerobic Gram-negative rods could be cultured from the caecal contents. The possibility that in one mouse the appearance of beta-aspartylglycine was related to a decrease in Gram-negative rods was ruled out by selective elimination of aerobic Gram-negative rods by using polymyxin B. This suggests that other bacteria concomitantly eliminated with the enterococci and aerobic Gram-negative rods, directly or indirectly, could play a role in the accumulation of beta-aspartylglycine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 570395      PMCID: PMC1186141          DOI: 10.1042/bj1750807

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  THE AMINO ACID SEQUENCE OF PSEUDOMONAS CYTOCHROME C-551.

Authors:  R P AMBLER
Journal:  Biochem J       Date:  1963-11       Impact factor: 3.857

2.  Occurrence of beta-aspartyl and gamma-glutamyl oligopeptides in human urine.

Authors:  D L BUCHANAN; E E HALEY; R T MARKIW
Journal:  Biochemistry       Date:  1962-07       Impact factor: 3.162

3.  Studies on the in vivo metabolism of alpha- and beta-aspartyl-glycine-1-C14.

Authors:  D L BUCHANAN; E E HALEY; R T MARKIW; A A PETERSON
Journal:  Biochemistry       Date:  1962-07       Impact factor: 3.162

4.  The amino acid sequence around the reactive serine residue of some proteolytic enzymes.

Authors:  M A NAUGHTON; F SANGER; B S HARTLEY; D C SHAW
Journal:  Biochem J       Date:  1960-10       Impact factor: 3.857

5.  Cultural and biochemical characteristics of the genus Chromobacterium.

Authors:  P H SNEATH
Journal:  J Gen Microbiol       Date:  1956-08

Review 6.  Strategy and tactics in protein chemistry.

Authors:  B S Hartley
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

7.  Purification and properties of a beta-aspartyl peptidase from Escherichia coli.

Authors:  E E Haley
Journal:  J Biol Chem       Date:  1968-11-10       Impact factor: 5.157

8.  The hydrolysis of beta-aspartyl peptides by rat tissue.

Authors:  F E Dorer; E E Haley; D L Buchanan
Journal:  Arch Biochem Biophys       Date:  1968-09-20       Impact factor: 4.013

9.  Study of the dansylation reaction of amino acids, peptides and proteins.

Authors:  C Gros; B Labouesse
Journal:  Eur J Biochem       Date:  1969-02

10.  Quantitative studies of urinary beta-aspartyl oligopeptides.

Authors:  F E Dorer; E E Haley; D L Buchanan
Journal:  Biochemistry       Date:  1966-10       Impact factor: 3.162

  10 in total
  7 in total

1.  Confirmation of D-aspartic acid in the novel dipeptide beta-aspartylglycine isolated from tissue extract of Aplysia kurodai.

Authors:  M Sato; T Yamaguchi; N Kanno; Y Sato
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  Recolonization and colonization resistance of the large bowel after three methods of preoperative preparation of the gastrointestinal tract for elective colorectal surgery.

Authors:  A E van den Bogaard; W F Weidema; C P van Boven; D van der Waay
Journal:  J Hyg (Lond)       Date:  1986-08

3.  Influence of temocillin on colonisation resistance and consequences for therapy.

Authors:  H G De Vries-Hospers; W Hofstra; G W Welling; D Van der Waaij
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  Influence of quinolones on throat- and faecal flora of healthy volunteers.

Authors:  H G de Vries-Hospers; G W Welling; D van der Waaij
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

5.  The screening of four aminoglycosides in the selective decontamination of the digestive tract in mice.

Authors:  D van der Waaij; J Aberson; H A Thijm; G W Welling
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

6.  Effect of antibiotics on the human intestinal flora in mice.

Authors:  M P Hazenberg; M Van de Boom; M Bakker; J P Van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

7.  The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice.

Authors:  C H Emmelot; D van der Waaij
Journal:  J Hyg (Lond)       Date:  1980-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.